Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Ann Intern Med. 2020 Dec 29;174(3):289–297. doi: 10.7326/M20-4873

Figure 1.

Figure 1.

Cohort derivation and primary aldosteronism testing status, initial testing results, MRA use, and adrenalectomy status among participants who met inclusion criteria. MRA = mineralocorticoid receptor antagonist.